The White House is making exactly the wrong moves to prevent the next pandemic
The U.S. will be seen as a pariah in the global community if it does not play a collaborative role in preventing the next ...
unaids1h
The critical impact of the PEPFAR funding freeze for HIV across Latin America and the Caribbean
The U.S. decision in January to freeze all funding for U.S. foreign assistance, including for the U.S. President's Emergency ...
Medscape8h
Gonorrhea and Syphilis Cases Skyrocket in Europe
Researchers suggest that unprotected intercourse, an increase in the number of sexual partners, and changes in testing practices are potential causes.
The Lancet14h
Daniela Ligiero: driving action to end violence against children
Sexual violence against children and adolescents is a public health emergency because every country in the world is dealing ...
Trump’s aid cuts deny one million women a week access to contraception
The withdrawal of USAID funding enacted by Donald Trump is having an immediate impact in poor countries – with reproductive ...
unaids21h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
A new HIV prevention drug could get FDA approval this year
Preventing HIV infections could soon be as simple as two shots a year.
Healio22h
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Marketplace22h
The foreign aid freeze is affecting lifesaving HIV/AIDS treatment
The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...
Global Fund Seeks $18 Billion as US Retreats From Public Health
Financing for global health has never looked more dire as the world reels from US President Donald Donald Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...